BREG, INC.

BREG, INC. specializes in the design, development, and manufacturing of precision medical devices and related components, operating under NAICS 339113, which encompasses surgical and medical instrument manufacturing. The company’s technical expertise lies in high-tolerance machining, sterile packaging systems, and materials compliant with ISO 13485 and FDA QSR requirements. Their work involves the production of custom implants, diagnostic tooling, and reusable surgical instruments requiring rigorous validation and traceability protocols. BREG, INC. differentiates itself through its focus on small-batch, high-complexity manufacturing for regulated environments, with capabilities in CNC fabrication, surface finishing, and biocompatible material selection such as titanium alloys and medical-grade polymers. Award history is not available to infer specific agency relationships or project types, so no direct agency experience can be confirmed. Similarly, without recent contract data, no specific market engagements or procurement patterns can be detailed. The company’s primary industry focus is the medical device manufacturing sector, serving the niche of specialized instrumentation requiring stringent quality controls and regulatory adherence. Their market positioning centers on serving OEMs and healthcare technology firms that require contract manufacturing partners with proven expertise in low-volume, high-precision production for clinical use. BREG, INC. is structured as a small business under the 2L entity classification and is headquartered in Carlsbad, California, a hub for life sciences innovation. The company holds no government certifications, including 8(a), HUBZone, or WOSB status. Its geographic presence is localized to Southern California, with operations tailored to support regional medical device ecosystems and supply chain partners in the biotech and pharmaceutical sectors.